- Home
- HSPO vs ECOR Comparison
HSPO vs ECOR Comparison
Compare HSPO & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSPO
- ECOR
- Stock Information
- Founded
- HSPO 2014
- ECOR 2005
- Country
- HSPO United States
- ECOR United States
- Employees
- HSPO N/A
- ECOR N/A
- Industry
- HSPO Blank Checks
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HSPO Finance
- ECOR Health Care
- Exchange
- HSPO Nasdaq
- ECOR Nasdaq
- Market Cap
- HSPO 49.4M
- ECOR 50.1M
- IPO Year
- HSPO 2022
- ECOR 2018
- Fundamental
- Price
- HSPO $12.11
- ECOR $5.00
- Analyst Decision
- HSPO
- ECOR Strong Buy
- Analyst Count
- HSPO 0
- ECOR 2
- Target Price
- HSPO N/A
- ECOR $25.50
- AVG Volume (30 Days)
- HSPO 3.5K
- ECOR 182.1K
- Earning Date
- HSPO 01-01-0001
- ECOR 05-07-2025
- Dividend Yield
- HSPO N/A
- ECOR N/A
- EPS Growth
- HSPO N/A
- ECOR N/A
- EPS
- HSPO N/A
- ECOR N/A
- Revenue
- HSPO N/A
- ECOR $26,458,000.00
- Revenue This Year
- HSPO N/A
- ECOR $26.76
- Revenue Next Year
- HSPO N/A
- ECOR $44.87
- P/E Ratio
- HSPO $34.81
- ECOR N/A
- Revenue Growth
- HSPO N/A
- ECOR 41.54
- 52 Week Low
- HSPO $10.97
- ECOR $4.47
- 52 Week High
- HSPO $12.41
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- HSPO 66.53
- ECOR 38.81
- Support Level
- HSPO $11.82
- ECOR $4.86
- Resistance Level
- HSPO $12.14
- ECOR $5.49
- Average True Range (ATR)
- HSPO 0.02
- ECOR 0.47
- MACD
- HSPO 0.03
- ECOR 0.07
- Stochastic Oscillator
- HSPO 91.43
- ECOR 38.08
About HSPO Horizon Space Acquisition I Corp.
Horizon Space Acquisition I Corp is a blank check company.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.